Action DNA GINKGO BIOWORKS HOLDINGS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Ginkgo Bioworks Holdings, Inc.

Actions

DNA

US37611X1000

Marché Fermé - Nyse
Autres places de cotation
 22:00:02 23/04/2024 		Varia. 5j. Varia. 1 janv.
0,8705 USD +3,29 % Graphique intraday de Ginkgo Bioworks Holdings, Inc. -4,71 % -48,49 %
16/04 Il Granaio delle Idee et Ginkgo Bioworks annoncent une collaboration stratégique visant à optimiser les souches de levain pour les produits de boulangerie CI
11/04 Transcript : Ginkgo Bioworks Holdings, Inc. Presents at Ginkgo's Annual Ferment Conference 2024, Apr-11-2024

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Global Retail Giant Enhances Warehouse Efficiency with Vuzix (VUZI) Smart Glasses Rollout
Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products
Il Granaio delle Idee and Ginkgo Bioworks Announces Strategic Collaboration to Optimize Sourdough Strains for Bakery Products
Modalis Announces Partnership with Ginkgo Bioworks
Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces 'Lab Data as a Service'
Ginkgo Bioworks Acquires AgBiome's Platform Assets
Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets
Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces "Lab Data as a Service"
Ginkgo Bioworks Expands Research Partnership With Novo Nordisk
Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain
Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles Outbreaks
Ginkgo Bioworks Partners With IdeeLab Biotechnology in Brazil
IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service
IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service
Ginkgo Bioworks to Host 5th Annual Ferment Conference
Ginkgo Bioworks, Prozomix Collaborate on Enzyme Development
Ginkgo Bioworks Acquires Modulus Therapeutics Cell Therapy Assets to Strengthen Next-Gen CAR Designs
Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing
Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing
Ginkgo Bioworks (NYSE: DNA) completed the acquisition of cell therapy platform assets of Modulus Therapeutics.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action DNA
  4. Actualités Ginkgo Bioworks Holdings, Inc.
  5. Autres langues